🇺🇸 FDA
Patent

US 12128044

Fused tricyclic compounds and uses thereof in medicine

granted A61KA61K31/427A61K31/429

Quick answer

US patent 12128044 (Fused tricyclic compounds and uses thereof in medicine) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/427, A61K31/429, A61K31/5025, A61K31/513